top of page
Search

ESC Congress Paris 2019

  • Eamon Mulvaney
  • Aug 26, 2019
  • 1 min read

ATXA Therapeutics and PAH-Hope team members, Prof. Therese Kinsella & Dr. Helen Reid are looking forward to the ESC Congress 2019 next week. They will be onsite presenting preclinical findings of NTP42 for the treatment of PAH (Pulmonary Arterial Hytertension).

ESC Congress 2019 together with World Congress of Cardiology

ESC Congress 2019 together with World Congress of Cardiology

Saturday 31 August - Wednesday 4 September 2019 Paris - France

 
 
 

Comments


Small Logo Gray.jpg

© 2025 ATXA Therapeutics Ltd. All Rights Reserved.

  • LinkedIn
  • X
  • Facebook
  • YouTube

TERMS OF USE

PRIVACY POLICY

Company number: 561857

UCD Conway Institute,

University College Dublin,

Belfield, Dublin 4, Ireland

Tel: +353 (0)1 525 2829

Contact Us

bottom of page